These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 27461930)

  • 1. Fecal microbiota transplantation for patients with steroid-resistant acute graft-versus-host disease of the gut.
    Kakihana K; Fujioka Y; Suda W; Najima Y; Kuwata G; Sasajima S; Mimura I; Morita H; Sugiyama D; Nishikawa H; Hattori M; Hino Y; Ikegawa S; Yamamoto K; Toya T; Doki N; Koizumi K; Honda K; Ohashi K
    Blood; 2016 Oct; 128(16):2083-2088. PubMed ID: 27461930
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fecal microbiota transplantation for acute graft-versus-host disease of the gut].
    Kakihana K
    Rinsho Ketsueki; 2017; 58(5):499-505. PubMed ID: 28592766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fecal microbiota transplantation in the treatment of intestinal steroid-resistant graft-versus-host disease: two case reports and a review of the literature.
    Biernat MM; Urbaniak-Kujda D; Dybko J; Kapelko-Słowik K; Prajs I; Wróbel T
    J Int Med Res; 2020 Jun; 48(6):300060520925693. PubMed ID: 32527171
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multi-omics Analysis of a Fecal Microbiota Transplantation Trial Identifies Novel Aspects of Acute GVHD Pathogenesis.
    Rashidi A; Ebadi M; Rehman TU; Elhusseini H; Kazadi D; Halaweish H; Khan MH; Hoeschen A; Cao Q; Luo X; Kabage AJ; Lopez S; Ramamoorthy S; Holtan SG; Weisdorf DJ; Khoruts A; Staley C
    Cancer Res Commun; 2024 Jun; 4(6):1454-1466. PubMed ID: 38767452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treating Steroid Refractory Intestinal Acute Graft-vs.-Host Disease With Fecal Microbiota Transplantation: A Pilot Study.
    Qi X; Li X; Zhao Y; Wu X; Chen F; Ma X; Zhang F; Wu D
    Front Immunol; 2018; 9():2195. PubMed ID: 30319644
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study of 19 cases of steroid-refractory gastrointestinal acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation with fecal microbiota transplantation].
    Zheng YY; Yang XT; Lin GQ; Bian MR; Si YJ; Zhang XX; Zhang YM; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2023 May; 44(5):401-407. PubMed ID: 37550190
    [No Abstract]   [Full Text] [Related]  

  • 7. Fecal microbiota transplantation in capsules for the treatment of steroid refractory and steroid dependent acute graft vs. host disease: a pilot study.
    Youngster I; Eshel A; Geva M; Danylesko I; Henig I; Zuckerman T; Fried S; Yerushalmi R; Shem-Tov N; Fein JA; Bomze D; Shimoni A; Koren O; Shouval R; Nagler A
    Bone Marrow Transplant; 2024 Mar; 59(3):409-416. PubMed ID: 38212672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of intestinal graft-versus-host disease with unrelated donor fecal microbiota transplantation capsules: A case report.
    Mao D; Jiang Q; Sun Y; Mao Y; Guo L; Zhang Y; Man M; Ouyang G; Sheng L
    Medicine (Baltimore); 2020 Sep; 99(38):e22129. PubMed ID: 32957333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fecal Microbiota Transplantation: Restoring the Injured Microbiome after Allogeneic Hematopoietic Cell Transplantation.
    DeFilipp Z; Hohmann E; Jenq RR; Chen YB
    Biol Blood Marrow Transplant; 2019 Jan; 25(1):e17-e22. PubMed ID: 30408565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fecal microbiota transplantation for graft-versus-host disease in children and adults: methods, clinical effects, safety].
    Goloshchapov OV; Chukhlovin AB; Bakin EA; Stanevich OV; Klementeva RV; Shcherbakov AA; Shvetsov AN; Suvorova MA; Bondarenko SN; Kucher MA; Kulagin AD; Zubarovskaya LS; Moiseev IS
    Ter Arkh; 2020 Sep; 92(7):43-54. PubMed ID: 33346444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Third-party fecal microbiota transplantation following allo-HCT reconstitutes microbiome diversity.
    DeFilipp Z; Peled JU; Li S; Mahabamunuge J; Dagher Z; Slingerland AE; Del Rio C; Valles B; Kempner ME; Smith M; Brown J; Dey BR; El-Jawahri A; McAfee SL; Spitzer TR; Ballen KK; Sung AD; Dalton TE; Messina JA; Dettmer K; Liebisch G; Oefner P; Taur Y; Pamer EG; Holler E; Mansour MK; van den Brink MRM; Hohmann E; Jenq RR; Chen YB
    Blood Adv; 2018 Apr; 2(7):745-753. PubMed ID: 29592876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fecal microbiota transfer for refractory intestinal graft-versus-host disease - Experience from two German tertiary centers.
    Goeser F; Sifft B; Stein-Thoeringer C; Farowski F; Strassburg CP; Brossart P; Higgins PG; Scheid C; Wolf D; Holderried TAW; Vehreschild MJGT; Cruz Aguilar MR
    Eur J Haematol; 2021 Aug; 107(2):229-245. PubMed ID: 33934412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Donor fecal microbiota transplantation ameliorates intestinal graft-versus-host disease in allogeneic hematopoietic cell transplant recipients.
    van Lier YF; Davids M; Haverkate NJE; de Groot PF; Donker ML; Meijer E; Heubel-Moenen FCJI; Nur E; Zeerleder SS; Nieuwdorp M; Blom B; Hazenberg MD
    Sci Transl Med; 2020 Aug; 12(556):. PubMed ID: 32801142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intestinal Microbiota at Engraftment Influence Acute Graft-Versus-Host Disease
    Han L; Jin H; Zhou L; Zhang X; Fan Z; Dai M; Lin Q; Huang F; Xuan L; Zhang H; Liu Q
    Front Immunol; 2018; 9():669. PubMed ID: 29740427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
    Webb BJ; Brunner A; Ford CD; Gazdik MA; Petersen FB; Hoda D
    Transpl Infect Dis; 2016 Aug; 18(4):628-33. PubMed ID: 27214585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant Enterobacteriaceae colonization: a case report and literature review.
    Su F; Luo Y; Yu J; Shi J; Zhao Y; Yan M; Huang H; Tan Y
    Eur J Med Res; 2021 Apr; 26(1):37. PubMed ID: 33910622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and Efficacy of Fecal Microbiota Transplantation for Grade IV Steroid Refractory GI-GvHD Patients: Interim Results From FMT2017002 Trial.
    Zhao Y; Li X; Zhou Y; Gao J; Jiao Y; Zhu B; Wu D; Qi X
    Front Immunol; 2021; 12():678476. PubMed ID: 34220825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Longitudinal dynamics of gut bacteriome, mycobiome and virome after fecal microbiota transplantation in graft-versus-host disease.
    Zhang F; Zuo T; Yeoh YK; Cheng FWT; Liu Q; Tang W; Cheung KCY; Yang K; Cheung CP; Mo CC; Hui M; Chan FKL; Li CK; Chan PKS; Ng SC
    Nat Commun; 2021 Jan; 12(1):65. PubMed ID: 33397897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prebiotics protect against acute graft-versus-host disease and preserve the gut microbiota in stem cell transplantation.
    Yoshifuji K; Inamoto K; Kiridoshi Y; Takeshita K; Sasajima S; Shiraishi Y; Yamashita Y; Nisaka Y; Ogura Y; Takeuchi R; Toya T; Igarashi A; Najima Y; Doki N; Kobayashi T; Ohashi K; Suda W; Atarashi K; Shiota A; Hattori M; Honda K; Kakihana K
    Blood Adv; 2020 Oct; 4(19):4607-4617. PubMed ID: 32991720
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fecal Microbiota Transplantation for Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation: Expanding the Horizon into Pediatrics.
    Gray AN; DeFilipp Z
    Transplant Cell Ther; 2023 Aug; 29(8):484-491. PubMed ID: 37169290
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.